Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
L Yang, Z Wang - European journal of medicinal chemistry, 2023 - Elsevier
The ongoing COVID-19 pandemic has resulted in millions of deaths globally, highlighting
the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2 …
the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2 …
Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts
Z Wang, L Yang - Journal of Ethnopharmacology, 2021 - Elsevier
Ethnopharmacological relevance Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection causes coronavirus disease 2019 (COVID-19), a highly pathogenic virus …
CoV-2) infection causes coronavirus disease 2019 (COVID-19), a highly pathogenic virus …
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
JT Jan, TJR Cheng, YP Juang, HH Ma… - Proceedings of the …, 2021 - National Acad Sciences
The outbreak of COVID-19 caused by SARS-CoV-2 has resulted in more than 50 million
confirmed cases and over 1 million deaths worldwide as of November 2020. Currently, there …
confirmed cases and over 1 million deaths worldwide as of November 2020. Currently, there …
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS …
The scientific community is focused on developing antiviral therapies to mitigate the impacts
of the ongoing novel coronavirus disease 2019 (COVID-19) outbreak. This will be facilitated …
of the ongoing novel coronavirus disease 2019 (COVID-19) outbreak. This will be facilitated …
In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease
Currently, the new coronavirus disease 2019 (COVID-19) is a global pandemic without any
well-calibrated treatment. To inactivate the SARS-CoV-2 virus that causes COVID-19, the …
well-calibrated treatment. To inactivate the SARS-CoV-2 virus that causes COVID-19, the …
A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)
F Huang, Y Li, ELH Leung, X Liu, K Liu, Q Wang… - Pharmacological …, 2020 - Elsevier
The epidemic of pneumonia (COVID-19) caused by novel coronavirus (SARS-CoV-2)
infection has been listed as a public health emergency of international concern by the World …
infection has been listed as a public health emergency of international concern by the World …
Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
CZ Chen, M Xu, M Pradhan, K Gorshkov… - ACS Pharmacology & …, 2020 - ACS Publications
While vaccine development will hopefully quell the global pandemic of COVID-19 caused by
SARS-CoV-2, small molecule drugs that can effectively control SARS-CoV-2 infection are …
SARS-CoV-2, small molecule drugs that can effectively control SARS-CoV-2 infection are …
Targeting proteases for treating COVID-19
The unprecedented pandemic of coronavirus disease 2019 (COVID-19) demands effective
treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The …
treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The …
[HTML][HTML] A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19
The recently discovered coronavirus, known as SARS-CoV-2, is a highly contagious and
potentially lethal viral infection that was declared a pandemic by the World Health …
potentially lethal viral infection that was declared a pandemic by the World Health …
The potential of antiviral peptides as COVID-19 therapeutics
To date, more than 17 million cases of coronavirus disease 2019 (COVID-19) and 900,000
deaths have been reported globally (World Health Organization, 2020). Major collaborative …
deaths have been reported globally (World Health Organization, 2020). Major collaborative …